C-RAD AB SER'B'NPV revenue for the last year amounted to 424.60 M SEK, the most of which — 348.44 M SEK — came from its highest performing source at the moment, Radiotherapy of Patients with Cancer. The greatest contribution to the revenue figure was made by EMEA — last year it brought C-RAD AB SER'B'NPV 220.01 M SEK.